Filed: 5/5/2026ACC: 0001193125-26-206555
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $141.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$141.41M
Total AUM (reported)
22.50M
Total Shares
Allocation by class
COMMON STOCK$134.33M95.0%
COMMON SHARES$7.08M5.0%
Portfolio Concentration
Top 3$104.13M73.6%
4–10$37.28M26.4%
Top 3 weight
73.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.50M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
22.50M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares3.18M
TypeSH
Market value$52.32M
37.00%
Sole
0.00
Shared
3.18M
None
0.00
Century Therapeutics, Inc.
OTRShares12.17M
TypeSH
Market value$27.50M
19.44%
Sole
0.00
Shared
12.17M
None
0.00
Lenz Therapeutics, Inc.
OTRShares2.66M
TypeSH
Market value$24.31M
17.19%
Sole
0.00
Shared
2.66M
None
0.00
Jade Biosciences, Inc.
OTRShares1.53M
TypeSH
Market value$21.44M
15.16%
Sole
0.00
Shared
1.53M
None
0.00
Contineum Therapeutics, Inc.
OTRShares542.63K
TypeSH
Market value$7.09M
5.01%
Sole
0.00
Shared
542.63K
None
0.00
CRISPR Therapeutics AG
OTRShares148.83K
TypeSH
Market value$7.08M
5.01%
Sole
0.00
Shared
148.83K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$1.23M
0.87%
Sole
0.00
Shared
2.01M
None
0.00
Tempest Therapeutics, Inc.
OTRShares269.77K
TypeSH
Market value$442.4K
0.31%
Sole
0.00
Shared
269.77K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 3.18M | SH | $52.32M 37.00% | 0.00 | 3.18M | 0.00 |
Century Therapeutics, Inc.OTR | Common Stock | 12.17M | SH | $27.50M 19.44% | 0.00 | 12.17M | 0.00 |
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $24.31M 17.19% | 0.00 | 2.66M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 1.53M | SH | $21.44M 15.16% | 0.00 | 1.53M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $7.09M 5.01% | 0.00 | 542.63K | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $7.08M 5.01% | 0.00 | 148.83K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $1.23M 0.87% | 0.00 | 2.01M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $442.4K 0.31% | 0.00 | 269.77K | 0.00 |